Thursday, April 7th, 2016 adds Atopic Dermatitis Pipeline Market Research 2016 to its database, providing in-depth, high quality, transparent and market-driven, expert’s analysis.

Companies Profile discussed in this research:  Abeome Corporation, Accolade Pharmaceuticals, LLC, AlbireoPharma, Almirall, S.A., Amgen Inc., Amorepacific Corporation, Anacor Pharmaceuticals, Inc., AnaMar AB, AnaptysBio, Inc., AnGes MG, Inc., Aquinox Pharmaceuticals Inc., arGEN-X BV, Blueberry Therapeutics Ltd, Brickell Biotech, Inc., Celgene Corporation, ChemoCentryx, Inc., ChironWells GmbH, Chugai Pharmaceutical Co., Ltd., Creabilis SA, Delenex Therapeutics AG, Dermira Inc., Dr. August Wolff GmbH & Co. KG Arzneimittle, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Foamix Pharmaceuticals Ltd., Fountain Biopharma Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Grupo Ferrer Internacional, S.A., Han Wha Pharma Co., Ltd., HanAll Biopharma Co., Ltd., Herantis Pharma Plc, Immune Pharmaceuticals Inc., Inflamalps SA, Japan Tobacco Inc., Johnson & Johnson, Kineta, Inc., LegoChem Biosciences, Inc, LEO Pharma A/S, Madam Therapeutics B.V., MedImmune, LLC, NeoPharm Co., Ltd., Novan, Inc., Novartis AG, Orbis Biosciences, Inc., Otsuka Holdings Co., Ltd., Oxagen Limited, Pfizer Inc., Pharis Biotec GmbH, Pharmedartis GmbH, Provectus Biopharmaceuticals, Inc, Regeneron Pharmaceuticals, Inc., Signum Dermalogix, Inc, Spherium Biomed S.L., sterna biologicals Gmbh & Co KG, Sucampo Pharmaceuticals, Inc., Sun Pharma Advanced Research Company Ltd., SWITCH Biotech LLC, Takeda Pharmaceutical Company Limited, Thesan Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Vicore Pharma AB, Vitae Pharmaceuticals, Inc., VivaCell Biotechnology Espana S.L., Xencor, Inc. and Ziarco Pharma Ltd.

Inquire more about this research

The report provides comprehensive information on the therapeutics under development for Atopic dermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Atopic dermatitis and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Complete research across 351 pages



  • The report provides a snapshot of the global therapeutic landscape of Atopic dermatitis
  • The report reviews pipeline therapeutics for Atopic dermatitis by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved Atopic dermatitis therapeutics and enlists all their major and minor projects
  • The report assesses Atopic dermatitis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Atopic dermatitis

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Atopic dermatitis
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Atopic dermatitis pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

File Library

Contact Profile

RnR Market Research

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus:



RSS / Feeds:

Ritesh Tiwari
P: + 1 888 391 5441


Atopic dermatitis Therapeutic Products under Development, Key Players in Atopic dermatitis Therapeutics, Atopic dermatitis Pipeline Overview, Atopic dermatitis Pipeline, Atopic dermatitis Pipeline Assessment




More Formats

View QR Code